Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5

Affiliations

A. Bosque: Department of Pathology, University of Utah, Salt Lake City, UT 84132, USA
A. Macedo: Department of Pathology, University of Utah, Salt Lake City, UT 84132, USA
A. Spivak: Department of Medicine, University of Utah, Salt Lake City, UT 84132, USA
C.L. Novis: Department of Pathology, University of Utah, Salt Lake City, UT 84132, USA
L.J. Martins: Department of Pathology, University of Utah, Salt Lake City, UT 84132, USA
M. Szaniawski: Department of Pathology, University of Utah, Salt Lake City, UT 84132, USA
N.M. Archin: Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
P.A. Luciw: Department of Pathology and Laboratory Medicine, School of Medicine, University of California at Davis, Davis, CA 95616, USA
D.M. Margolis: Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
V. Planelles: Department of Pathology, University of Utah, Salt Lake City, UT 84132, USA

Abstract

No abstracts available.